SIVEXTRO™ approved to treat serious skin infections

Cubist Pharmaceuticals, Inc. has announced that the US Food and Drug Administration approved SIVEXTRO™ (tedizolid phosphate) for the treatment of adult acute bacterial skin and skin structure infections.

Source: Pharmacy Europe - June 26, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Dermatology approval Latest News mrsa SIVEXTRO skin infection Source Type: news